Rituximab and Cytokine Release Syndrome

Rituximab and Cytokine Release Syndrome

Rituximab is a biologic agent that is usually well tolerated. With its increasing use for a myriad of rheumatologic and immunologic conditions, post-marketing surveillance has revealed more side effects. Systemic inflammatory response syndrome associated with cytokine release syndrome (CRS) is a ver...

Full description

Bibliographic Details
Main Authors: Hrishikesh S. Kulkarni, Pashtoon Murtaza Kasi
Format: Article
Language:English
Published: Karger Publishers 2012-03-01
Series:Case Reports in Oncology
Subjects:
Rituximab
Cytokine release syndrome
Systemic inflammatory response syndrome
Mortality
Fatality
Lactic acidosis
Post-transplant lymphoproliferative disorder
Online Access:http://www.karger.com/Article/FullText/337577

Similar Items

Similar Items